Developing the adjuvants of tomorrow
Biosector wants to take a leading part in the search for new and improved vaccine adjuvants which can solve unmet demands. The focus is both on developing new technologies as well as on optimizing and refining existing technologies and products. A small research team with internationally recognised expertise in immunology and vaccine adjuvants is dedicated to this task.
In the below sections you can read more about the primary projects.